BioSyent (CVE:RX) Share Price Crosses Above 50-Day Moving Average – Here’s Why

Shares of BioSyent Inc. (CVE:RX) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$11.35 and traded as high as C$11.43. BioSyent shares last traded at C$11.43, with a volume of 100 shares trading hands.

BioSyent Price Performance

The company has a quick ratio of 6.91, a current ratio of 6.13 and a debt-to-equity ratio of 3.19. The company has a market capitalization of C$129.46 million, a P/E ratio of 18.62 and a beta of 0.93. The business has a 50 day simple moving average of C$11.36 and a 200-day simple moving average of C$10.80.

Insider Buying and Selling at BioSyent

In related news, Senior Officer Robert Joseph March sold 4,775 shares of BioSyent stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of C$11.65, for a total transaction of C$55,628.75. Also, insider FAX Capital Corp. sold 112,400 shares of the business’s stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of C$11.28, for a total transaction of C$1,267,557.28. Over the last three months, insiders have sold 349,144 shares of company stock worth $3,903,370. 33.65% of the stock is owned by insiders.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.